Table 2. Treatment Outcomes of Patients with Convalescent Plasma Therapy (n=20).

Outcomes		Number of patients (%)
Mortality
	7-day mortality	1 (5)
	14-day mortality	2 (10)
	28-day mortality	4 (20)
	Overall mortality	5 (25)
Improvement in severity within 7 days
	WHO ordinal scale	8 (40)
	NIH severity	5 (25)
Improvement in severity within 14 days
	WHO ordinal scale	10 (50)
	NIH severity	10 (50)
Improvement of P/F ratio among survivors		15 (100)
Transfusion-related adverse events		0 (0)

WHO, World Health Organization; NIH, National Institute of Health.